It appears that Revive Therapeutics (CSE: RVV) has a budding superstar on its board of directors. Last week, Revive’s independent director William Jackson saw his private company sign a significant manufacturing agreement with that of Vaxart Inc, a clinical stage biotech firm that is focused on develop oral tablet vaccines. Last Thursday, Vaxart Inc (NASDAQ: … Continue reading Revive Therapeutics Director Signs Manufacturing Arrangement With Vaxart